News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
504,117 Results
Type
Article (10675)
Company Profile (142)
Press Release (493300)
Multimedia
Podcasts (6)
Webinars (6)
Section
Business (171077)
Career Advice (354)
Deals (26456)
Drug Delivery (12)
Drug Development (56611)
Employer Resources (17)
FDA (10993)
Job Trends (9135)
News (247903)
Policy (19626)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (686)
Accelerated approval (26)
ADA (19)
Adcomms (5)
Allergies (118)
Alliances (34421)
ALS (128)
Alzheimer's disease (985)
Antibody-drug conjugate (ADC) (256)
Approvals (11608)
Artificial intelligence (324)
ASCO (162)
Autoimmune disease (208)
Automation (27)
Bankruptcy (287)
Best Places to Work (7461)
BIO (38)
BIOSECURE Act (1)
Biosimilars (126)
Biotechnology (91)
Bladder cancer (142)
Brain cancer (29)
Breast cancer (518)
Cancer (3701)
Cardiovascular disease (228)
Career advice (290)
Career pathing (1)
CAR-T (169)
CDC (20)
Celiac Disease (1)
Cell therapy (483)
Cervical cancer (35)
Clinical research (50822)
Collaboration (1278)
Compensation (1381)
Complete response letters (42)
COVID-19 (1278)
CRISPR (64)
C-suite (721)
Cystic fibrosis (123)
Data (5816)
Denatured (4)
Depression (105)
Dermatology (68)
Diabetes (338)
Diagnostics (4433)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (154)
Drug pricing (17)
Drug shortages (4)
Duchenne muscular dystrophy (202)
Earnings (74366)
Editorial (3)
Employer branding (3)
Employer resources (16)
Events (89663)
Executive appointments (694)
FDA (13723)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (17)
Frontotemporal dementia (24)
Funding (939)
Gene editing (131)
Generative AI (11)
Gene therapy (343)
GLP-1 (321)
Government (1347)
Grass and pollen (5)
Guidances (293)
Healthcare (10105)
Hematology (99)
HIV (49)
Huntington's disease (22)
IgA nephropathy (65)
Immunology and inflammation (127)
Immuno-oncology (56)
Indications (166)
Infectious disease (1550)
Inflammatory bowel disease (139)
Inflation Reduction Act (5)
Influenza (120)
Intellectual property (251)
Interviews (52)
IPO (12662)
IRA (8)
Job creations (2071)
Job search strategy (272)
JPM (5)
Kidney cancer (14)
Layoffs (91)
Leadership (1)
Legal (5564)
Liver cancer (47)
Longevity (15)
Lung cancer (525)
Lymphoma (260)
Machine learning (29)
Management (3)
Manufacturing (535)
Marketing (6)
MASH (117)
Medical device (9373)
Medtech (9493)
Mergers & acquisitions (14791)
Metabolic disorders (713)
mRNA (94)
Multiple sclerosis (115)
NASH (4)
Neurodegenerative disease (224)
Neuropsychiatric disorders (43)
Neuroscience (1859)
NextGen: Class of 2026 (3323)
Non-profit (960)
Now hiring (3)
Obesity (238)
Opinion (20)
Ovarian cancer (158)
Pain (174)
Pancreatic cancer (192)
Parkinson's disease (200)
Partnered (11)
Patents (471)
Patient recruitment (496)
Peanut (38)
People (42142)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (16028)
Phase 2 (22415)
Phase 3 (15970)
Pipeline (6992)
Policy (47)
Postmarket research (1813)
Preclinical (6752)
Press Release (35)
Prostate cancer (198)
Psychedelics (9)
Radiopharmaceuticals (190)
Rare diseases (649)
Real estate (3128)
Recruiting (8)
Regulatory (16051)
Reports (17)
Research institute (699)
Resumes & cover letters (48)
Rett syndrome (39)
RNA editing (6)
RSV (95)
Schizophrenia (98)
Series A (154)
Series B (123)
Service/supplier (4)
Sickle cell disease (65)
Special edition (1)
Spinal muscular atrophy (119)
Sponsored (8)
Startups (2117)
Stomach cancer (3)
Supply chain (49)
Tariffs (2)
The Weekly (2)
Vaccines (534)
Venture capital (21)
Weight loss (80)
Women's health (73)
Date
Today (36)
Last 7 days (300)
Last 30 days (1196)
Last 365 days (20041)
2026 (11049)
2025 (20182)
2024 (24069)
2023 (27796)
2022 (36155)
2021 (39132)
2020 (36019)
2019 (24690)
2018 (18642)
2017 (19876)
2016 (19040)
2015 (25366)
2014 (22516)
2013 (18800)
2012 (20874)
2011 (21068)
2010 (20829)
Location
Africa (259)
Alabama (69)
Alaska (2)
Arizona (296)
Arkansas (11)
Asia (19848)
Australia (2491)
California (11633)
Canada (3080)
China (580)
Colorado (492)
Connecticut (403)
Delaware (274)
Europe (30349)
Florida (1760)
Georgia (369)
Hawaii (2)
Idaho (46)
Illinois (724)
India (48)
Indiana (357)
Iowa (14)
Japan (406)
Kansas (101)
Kentucky (33)
Louisiana (25)
Maine (25)
Maryland (1184)
Massachusetts (7735)
Michigan (300)
Minnesota (546)
Mississippi (4)
Missouri (78)
Montana (20)
Nebraska (11)
Nevada (114)
New Hampshire (60)
New Jersey (2655)
New Mexico (11)
New York (2751)
North Carolina (1304)
North Dakota (4)
Northern California (5787)
Ohio (278)
Oklahoma (14)
Oregon (15)
Pennsylvania (2235)
Puerto Rico (21)
Rhode Island (30)
South America (437)
South Carolina (76)
South Dakota (1)
Southern California (4811)
Tennessee (113)
Texas (1863)
United States (38313)
Utah (343)
Vermont (1)
Virginia (156)
Washington D.C. (39)
Washington State (900)
West Virginia (1)
Wisconsin (75)
504,117 Results for "respiratory motion inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NEREUS™ Powers Forward: Sponsors No. 47 IndyCar Entry, Celebrating 47 Years Since Last New U.S. Motion Sickness Treatment
July 16, 2026
·
2 min read
Immunology and inflammation
AstraZeneca bets up to $1.9B in respiratory disease collab with Sino Biopharmaceutical
In AstraZeneca’s third trip to Asia this year, the pharma secured ex-China rights to a dual inhibitor of PDE3 and PDE4, which in a Phase 2b study significantly improved lung function and lowered symptom burden in patients with chronic obstructive pulmonary disorder.
July 8, 2026
·
2 min read
·
Tristan Manalac
Press Releases
ENA Respiratory Appoints Melissa Faris to Board
April 23, 2026
·
3 min read
Press Releases
Altesa BioSciences Announces Upcoming Oral Presentation Featuring Novel Vapendavir Data at European Respiratory Society International Congress 2026
July 7, 2026
·
3 min read
Press Releases
ENA Respiratory Successfully Completes First Part of Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections
May 11, 2026
·
4 min read
Press Releases
Empirical Spine Announces First Commercial LimiFlex(R) Cases at Stanford Medicine, Marking U.S. Launch of Motion-Preserving Alternative to Fusion for Degenerative Spondylolisthesis
May 19, 2026
·
2 min read
Press Releases
Vanda Pharmaceuticals Announces U.S. Commercial Availability of NEREUS™ (tradipitant), the First New Pharmacologic Treatment for People with Motion Sickness in More Than 40 Years
May 4, 2026
·
8 min read
Press Releases
Vanda Pharmaceuticals Announces FDA Approval of NEREUS™ (tradipitant) for the Prevention of Vomiting Induced by Motion: A Historic Scientific Milestone in the Prevention of Motion Sickness
December 30, 2025
·
9 min read
Press Releases
European Commission Approves Merck’s ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants During Their First RSV Season
April 17, 2026
·
11 min read
Press Releases
Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit
April 1, 2026
·
6 min read
1 of 50,412
Next
